Skip to content
-
Subscribe to our newsletter & never miss our best posts. Subscribe Now!
Zumedha Equity Research Zumedha Equity Research

Research · Analysis · Insights

Zumedha Equity Research Zumedha Equity Research

Research · Analysis · Insights

  • Home
  • Stocks Analysis
    • Metals
    • Automotive Sector
      • Auto ancillary
    • Banking & Financial Services
    • Aviation Industry
    • Power & Energy
      • Cables & Wires
      • Battery Industries
    • IT & Tech
      • IT Services
      • Technology
      • Biotech & Life Science
    • Infrastructure Sector
    • Telecom
    • Hotels & Hospitality
    • Travel & Hospitality
    • Healthcare
      • Pharmaceutical Industry
    • Quick Commerce
    • Consumer Services
    • EMS Stocks
  • Mutual Funds Reviews
    • SmallCap Mutual Funds
    • Multicap MFs
    • SIP Calculator
  • Master Class
  • Calculators
    • MF Return Calculator
    • Loan Calculator
    • Tax Calculator
  • Home
  • Stocks Analysis
    • Metals
    • Automotive Sector
      • Auto ancillary
    • Banking & Financial Services
    • Aviation Industry
    • Power & Energy
      • Cables & Wires
      • Battery Industries
    • IT & Tech
      • IT Services
      • Technology
      • Biotech & Life Science
    • Infrastructure Sector
    • Telecom
    • Hotels & Hospitality
    • Travel & Hospitality
    • Healthcare
      • Pharmaceutical Industry
    • Quick Commerce
    • Consumer Services
    • EMS Stocks
  • Mutual Funds Reviews
    • SmallCap Mutual Funds
    • Multicap MFs
    • SIP Calculator
  • Master Class
  • Calculators
    • MF Return Calculator
    • Loan Calculator
    • Tax Calculator
Close

Search

Latest
August 30, 2026
Hindustan Unilever (HUL) Share Price Target & Stock Analysis Aug 2026
August 28, 2026
Indian Hotels DCF Valuation & Share Price Analysis Aug 2026
August 27, 2026
Jio Financial Services DCF Valuation & Share Price Analysis Aug 2026
August 25, 2026
Eicher Motors DCF Valuation and Share Price Analysis Aug 2026
August 25, 2026
Torrent Pharmaceuticals DCF Valuation and Share Price Analysis Aug 2026
August 15, 2026
Honasa Consumer Limited DCF Valuation & Share Price Analysis
August 15, 2026
Welspun Living Limited DCF Valuation & Share Price Analysis Aug 2026
August 13, 2026
Transformers & Rectifiers (India) Ltd DCF Valuation & Share Price Analysis Aug 2026
August 10, 2026
Ather Energy DCF Valuation and Share Price Analysis Aug 2026
August 8, 2026
Biocon Ltd DCF Valuation and Share Price Analysis Aug 2026
Home/Retail & Consumer Discretionary/Hindustan Unilever (HUL) Share Price Target & Stock Analysis Aug 2026
Retail & Consumer Discretionary

Hindustan Unilever (HUL) Share Price Target & Stock Analysis Aug 2026

August 30, 2026 8 Min Read
Zumedha Equity Research
Research . Analysis . Insights
CMP ₹2,007
as on 27 Aug 2026
ACCUMULATE ON DIPS

Hindustan Unilever (HUL) Share Price Target & Stock Analysis

India’s largest FMCG company — a portfolio of 50+ brands across Home Care, Beauty & Wellbeing and Foods & Refreshment, sold through one of the deepest distribution networks in the country. A quality compounder trading near multi-year price lows even as underlying volumes have re-accelerated.
By Zumedha Equity Research  ·  Published/Updated: 29 Aug 2026
NSE
HINDUNILVR
BSE
500696
ISIN
INE030A01027
Face Value
₹1.00
52W H/L
₹2,705 / ₹2,005
Mkt Cap
₹4,71,563 Cr
Shares O/S
~235.0 Cr
Avg Vol (approx)
15–20 L
Index
Sensex, Nifty50, BSE100
Promoter Holding
61.90%
CMP
₹2,007
Mkt Cap
₹4.72L Cr
52W H/L
2,705/2,005
P/E (TTM)
42.8x
Revenue (TTM)
₹66,052 Cr
PAT (TTM)
₹14,971 Cr
EBITDA Margin
23.0%
01

Business Overview

This Hindustan Unilever (NSE: HINDUNILVR, BSE: 500696) stock analysis covers HUL’s business model, historical financials, valuation methods and share price target ranges, to help long-term investors evaluate whether the stock is a buy at current levels.

Hindustan Unilever Limited (HUL), a 61.9%-owned subsidiary of Unilever PLC, is India’s largest fast-moving consumer goods company by both revenue and market capitalisation. Founded in 1933 and headquartered in Mumbai, HUL operates through three reporting segments — Home Care (Surf Excel, Vim, Comfort, Rin), Beauty & Wellbeing (Dove, Lux, Lakme, Pond’s, Pears) and Foods & Refreshment (Knorr, Kissan, Bru, Lipton, Horlicks) — spanning 16 FMCG categories with a portfolio of over 50 brands, including 19 individual brands generating turnover above ₹1,000 crore annually.

The company’s core competitive moat rests on unmatched rural and urban distribution reach, decades of brand equity built through sustained advertising investment, and access to Unilever’s global R&D and innovation pipeline. HUL has been actively reshaping its portfolio — including the demerger of its ice-cream business (Kwality Wall’s) as a separately listed entity, completed in the December 2025 quarter — to sharpen focus on its core Home Care, Beauty & Wellbeing and Foods & Refreshment franchise and to unlock standalone value for the spun-off business.

Business Segments
3
Brand Portfolio
50+
₹1,000 Cr+ Brands
19
Promoter (Unilever)
61.9%

Pros

  • Company is almost debt-free, giving significant balance-sheet flexibility
  • Healthy dividend payout averaging over 90% of profit in recent years
  • Market-leading distribution network with deep general trade and e-commerce reach
  • ROE of 31% and ROCE of 28.4% reflect a highly capital-efficient, asset-light model

Cons

  • Stock trades at ~9.7x book value despite a mature, single-digit-growth core business
  • Compounded sales growth of just ~6.5% over the past five years
  • Reported earnings include a large one-off gain (ice-cream demerger) that inflates headline profit
02

Historical Financials

HUL has compounded revenue at a modest 7% over the past decade, with profit compounding faster at 14% aided by margin expansion and other-income gains. FY26 (year ended March 2026) reported net profit of ₹15,059 crore was inflated by an exceptional ~₹4,900 crore other-income spike in the December 2025 quarter, tied to the ice-cream business demerger; excluding this one-off, underlying/core profit growth is closer to mid-to-high single digits, consistent with the TTM profit growth of just 4%.

Consolidated (₹ Cr)FY22FY23FY24FY25FY26TTM
Sales52,44660,58061,89661,32864,46866,052
Operating Profit (EBITDA)12,85714,14714,65914,69815,03915,347
OPM %25%23%24%24%23%23%
Other Income2194488171,3554,9234,933
Net Profit8,89210,14310,28210,67115,05914,971
EPS (₹)37.7943.0743.7445.3264.0163.66
Free Cash Flow7,9958,98014,01210,6249,667—
10Y Sales CAGR
7%
10Y Profit CAGR
14%
5Y Sales CAGR
7%
TTM Profit Growth
4%

Q1 FY27 (June 2026 quarter) marked the strongest quarterly performance in 13 quarters, with reported sales of ₹17,341 crore, underlying sales growth (USG) of 10% split evenly between volume and price, and EBITDA growing 8% YoY to ₹3,947 crore at a 23% margin. Reported net profit fell ~3% YoY only because the year-ago quarter carried a one-off tax credit.

03

DCF Valuation

A 10-year discounted free-cash-flow model is built off a FY26 base free cash flow of ₹9,667 crore, with explicit growth tapering from 10% in year one to 6% by year ten, a terminal growth rate of 5%, and a WACC of 12%.

10-Year FCF Projection & Discounting (₹ Cr)

YearY1Y2Y3Y4Y5Y6Y7Y8Y9Y10
FCF10,63411,59112,63413,64514,73715,76916,87317,88518,95820,096
PV @ 12%9,4959,2408,9938,6728,3627,9897,6347,2256,8356,471
PV of Explicit FCF
₹80,916 Cr
PV of Terminal Value
₹97,065 Cr
Enterprise Value
₹1,77,981 Cr
DCF Fair Value / Share
₹793

The DCF-derived intrinsic value of ~₹793/share sits well below CMP, largely a function of the conservative 12% WACC and 5% terminal growth applied to a business now compounding sales at only high-single-digits. This is a common outcome for slow-but-steady FMCG compounders and should be read as a margin-of-safety floor rather than a market-consistent target — the market has historically paid a substantial premium over DCF-implied value for HUL’s brand moat, pricing power and capital efficiency.

04

Relative Valuation & Peer Multiples

HUL trades at the lower end of its own five-year valuation band but remains one of the more richly-valued large-cap FMCG names on an absolute basis, reflecting its scale, brand depth and consistency of execution.

CompanyMkt Cap (₹ Cr)P/E (x)ROE (%)Comment
Hindustan Unilever4,71,56342.831.0Largest FMCG, diversified portfolio
ITC Ltd~5,60,000~28–30~47.8Diversified; cigarettes + FMCG
Nestlé India~2,84,800~70–78~87.3Premium pricing power, richest multiple
Britannia Industries—~48–52~52.2Bakery/dairy focus
Dabur India—~38–42—Ayurveda/naturals, mid-cap scale
Godrej Consumer Products—~42–46—Home & personal care

Applying a peer-consistent large-cap FMCG P/E band of 38–45x to HUL’s normalized/adjusted earnings power (ex the one-off demerger gain) implies a fair value range of roughly ₹1,850–₹2,150/share. On EV/EBITDA, HUL currently trades near 30x TTM EBITDA; applying a 26–32x peer-consistent band implies a broadly similar range of ₹1,900–₹2,000/share.

05

Asset-Based Valuation (NAV)

HUL is an asset-light, brand-driven FMCG business; its balance sheet (book value of ₹207/share) captures manufacturing assets and working capital but not the decades of brand equity, distribution reach or intangible goodwill the market prices in. The stock’s 9.7x price-to-book multiple is therefore largely a function of intangible value rather than tangible net assets. NAV serves here only as a deep-value floor (₹207/share) and carries low weight in the overall synthesis — a pure asset-based lens materially understates HUL’s true worth.

06

Earnings Power Value (EPV)

EPV values the business purely on its current, sustainable earnings power with no credit for future growth — a useful conservative cross-check against the DCF.

Normalized EBIT (FY26)
₹13,706 Cr
NOPAT (~25% tax)
₹10,280 Cr
EPV (NOPAT / WACC)
₹85,667 Cr
EPV / Share
₹401

At ~₹401/share, EPV confirms that a meaningful share of HUL’s current valuation is attributable to expected future growth and brand-driven pricing power rather than today’s earnings alone — consistent with a premium, quality-compounder profile rather than a deep-value setup.

07

Sum-of-the-Parts (SOTP)

Following the ice-cream business demerger, HUL’s remaining operations are assessed across its three reporting segments using illustrative EV/Sales multiples that reflect relative margin and growth profiles.

SegmentAnnualized Revenue (₹ Cr)EV/Sales (x)Segment EV (₹ Cr)
Home Care26,2164.0x1,04,864
Beauty & Wellbeing16,3327.0x1,14,324
Foods & Refreshment26,8165.0x1,34,080
Total EV3,53,268

Adding net cash of ~₹8,500 crore, SOTP implies an equity value of approximately ₹1,540/share — a useful mid-point anchor sitting between the conservative earnings-based methods (DCF, EPV) and the market-based relative valuation.

08

Buy Range

Strong Buy
Below ₹1,700
Deep value zone, closer to earnings-power/SOTP floor
Accumulate
₹1,700 – ₹1,950
Attractive relative to peer-consistent multiples
Fair Value
₹1,950 – ₹2,150
Broadly in line with peer P/E and EV/EBITDA bands
09

Buy Scenario

Bear
~₹1,700
USG slows to mid-single digits; commodity inflation compresses margins; multiple de-rates to ~30x
Base
₹2,300 – ₹2,450
USG sustains 8–9%; margins stable near 23%; multiple holds at 35–38x
Bull
₹2,900 – ₹3,100
Double-digit USG sustained (as in Q1 FY27); premiumization drives margin expansion; re-rating to 42–45x
10

Sell Range

Reduce
₹2,150 – ₹2,350
Above peer-consistent fair value band
Exit
₹2,350 – ₹2,550
Valuation stretched relative to underlying growth
Avoid Fresh Buying
Above ₹2,550
Approaching 52-week high zone (₹2,705)
11

Sell Scenario

Overvalued
P/E > 45x
Trading materially above normalized earnings without corresponding growth acceleration
Exit Trigger
USG < 3% / OPM < 21%
Consecutive quarters of weak volume growth or sustained margin compression
Structural Break
Share loss
Sustained market-share erosion to D2C/quick-commerce private labels or regulatory shock
12

Future Growth

  • GST 2.0 tailwind: The September 2025 GST restructuring moved FMCG essentials to the 5% slab, directly boosting consumer affordability and volume demand across HUL’s core categories.
  • Premiumization: Continued mix-up within personal care (premium bars, Bodywash) and foods (lifestyle nutrition, coffee, Bru Gold, RTD beverages) supporting both growth and margin.
  • Channel expansion: Deepening general trade direct coverage alongside accelerating e-commerce and quick-commerce penetration.
  • Rural recovery: A gradual pickup in rural demand, historically HUL’s largest swing factor given its unmatched rural distribution depth.
  • Portfolio transformation: Post ice-cream demerger, sharper management focus and capital allocation toward the core three-segment portfolio.
  • Global innovation pipeline: Access to Unilever’s global R&D supports steady new product launches across categories.
13

Risks & Catalysts

Catalysts

  • Sustained double-digit USG as seen in Q1 FY27 continuing into subsequent quarters
  • Faster-than-expected rural demand recovery
  • Successful value unlock from the ice-cream business demerger
  • Easing commodity/palm oil inflation supporting margin expansion

Risks

  • Persistent palm oil and commodity cost inflation pressuring margins
  • Intensifying competition from D2C and regional FMCG challengers
  • Base-effect distortion in YoY profit comparisons following the one-off demerger gain
  • Slower-than-expected urban consumption recovery
  • Geopolitical volatility affecting input costs and currency
14

Institutional Ownership

CategorySep’23Jun’24Jun’25Dec’25Jun’26
Promoters61.90%61.90%61.90%61.90%61.90%
FIIs13.90%11.87%10.18%10.71%9.50%
DIIs11.90%14.09%15.99%15.68%16.92%
Government0.04%0.05%0.07%0.07%0.07%
Public / Retail12.26%12.11%11.86%11.64%11.60%
No. of Shareholders11,76,41112,10,98911,67,94511,12,71311,15,507
Institutional Category (May 2026)Holding %
Insurance (incl. LIC)8.79%
Mutual Funds6.62%
Foreign Institutional Investors10.10%
Other Domestic Institutions0.99%

A clear multi-year rotation is visible: FII holding has steadily declined from ~14% (Sep 2023) to ~9.5% (Jun 2026), while DII holding — driven largely by domestic mutual funds and insurers led by LIC — has risen from ~12% to nearly 17% over the same period. Promoter holding has remained rock-steady at 61.90%, signalling no change in Unilever’s long-term commitment to its Indian subsidiary. The steady DII accumulation even as the stock underperformed (down 22% over one year) suggests domestic institutional conviction in HUL’s long-term compounding despite near-term growth softness.

15

Frequently Asked Questions — HUL Stock

What is the share price target for Hindustan Unilever (HUL)?

Based on a blend of DCF, SOTP and peer-relative valuation, fair value works out to roughly ₹1,850–₹2,000, with a base-case scenario target of ₹2,300–₹2,450 over the next few years if underlying sales growth sustains at 8–9%.

Is HUL a good stock to buy right now?

HUL is a high-quality, near-debt-free compounder, but at the current price it is broadly fair-to-fully valued rather than cheap. This analysis favours accumulating on dips toward ₹1,700–₹1,950 over chasing the stock at current levels.

What is a good buy price range for HUL shares?

The Buy Range section of this report outlines a Strong Buy zone below ₹1,700, an Accumulate zone of ₹1,700–₹1,950, and a Fair Value zone of ₹1,950–₹2,150.

At what price should I consider selling or reducing HUL?

The Sell Range section flags ₹2,150–₹2,350 as a Reduce zone, ₹2,350–₹2,550 as an Exit zone, and levels above ₹2,550 (near the 52-week high of ₹2,705) as a zone to avoid fresh buying.

What are the key risks to HUL’s stock price?

Key risks include persistent commodity/palm oil cost inflation, rising competition from D2C and regional FMCG challengers, a slower-than-expected urban demand recovery, and base-effect distortions in reported profit following the FY26 ice-cream business demerger gain.

Verdict

Weighing the DCF (~₹793), EPV (~₹401), SOTP (~₹1,540) and NAV (~₹207) floors against market-consistent relative valuation on P/E and EV/EBITDA (~₹1,850–₹2,150), a probability-weighted synthesis places fair value in the ₹1,850–₹2,000 band — modestly below the current market price of ₹2,007. HUL remains a high-quality, near-debt-free compounder with a re-accelerating volume story (Q1 FY27’s highest USG in 13 quarters) and steady domestic institutional accumulation, but the stock is not statistically cheap: five-year sales growth of just ~6.5% sits alongside a ~9.7x price-to-book multiple. This analysis suggests investors already holding HUL stay invested for the long-term compounding and dividend profile, while fresh capital is better deployed on weakness toward the ₹1,700–₹1,950 accumulate zone rather than chased at current levels, with a multi-year investment horizon appropriate given the business’s low-volatility, high-visibility earnings character.

This report has been prepared by Zumedha Equity Research for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security. All data, financial figures and estimates are sourced from publicly available information believed to be reliable but not guaranteed for accuracy or completeness, and are subject to change without notice. Valuation methods, assumptions and scenario projections in this report reflect analytical estimates and involve inherent uncertainty; actual results may differ materially. Past performance is not indicative of future results. Readers should conduct their own due diligence and consult a SEBI-registered investment advisor before making any investment decisions. Zumedha Equity Research and its authors accept no liability for any loss arising from the use of this report.

Related

Tags:

Large Cap Stocks
Author

Zumedha Research Team

Follow Me
Other Articles
Previous

Indian Hotels DCF Valuation & Share Price Analysis Aug 2026

Recent Posts

  • Hindustan Unilever (HUL) Share Price Target & Stock Analysis Aug 2026 August 30, 2026
  • Indian Hotels DCF Valuation & Share Price Analysis Aug 2026 August 28, 2026
  • Jio Financial Services DCF Valuation & Share Price Analysis Aug 2026 August 27, 2026
  • Eicher Motors DCF Valuation and Share Price Analysis Aug 2026 August 25, 2026
  • Torrent Pharmaceuticals DCF Valuation and Share Price Analysis Aug 2026 August 25, 2026

More Reports like this

  • Ather Energy DCF Valuation and Share Price Analysis Aug 2026
    Date
    August 10, 2026
  • Biocon Ltd DCF Valuation and Share Price Analysis Aug 2026
    Date
    August 8, 2026
  • Indian Hotels DCF Valuation & Share Price Analysis Aug 2026
    Date
    August 28, 2026
  • Hindustan Unilever (HUL) Share Price Target & Stock Analysis Aug 2026
  • Indian Hotels DCF Valuation & Share Price Analysis Aug 2026
  • Jio Financial Services DCF Valuation & Share Price Analysis Aug 2026
  • Eicher Motors DCF Valuation and Share Price Analysis Aug 2026
  • Torrent Pharmaceuticals DCF Valuation and Share Price Analysis Aug 2026

Follow Us

© 2026 · All Rights Reserved by Zumedha.com. Site Links : About Us ♦ Terms of Use ♦ Privacy Policy ♦ Disclaimer ♦ Contact Us